OmniLytics Announces USDA/FSIS Allowance for Bacteriophage Treatment of Salmonella on Livestock

Bacteria control now available for use on live animals.

Salt Lake City — (March 21, 2007) The USDA’s Food Safety and Inspection Service (FSIS) has issued a no objection letter for use of Salmonella targeted bacteriophage manufactured by OmniLytics, Inc. applied as a mist, spray or wash on live animals prior to slaughter.

The BacWashTM branded bacteriophage products will be utilized to reduce the level of Salmonella contamination on the hides of livestock prior to further processing. Research has demonstrated the need to reduce the presence of Salmonella on the hide as it has been shown that during peak seasons hides harbor more bacteria than feces. It is also envisioned that bacteriophage produced by OmniLytics will be used to treat holding areas, transportation vehicles, containers and living quarters.

“The USDA’s allowance of the extended use of our BacWash product to treat Salmonella inserts for the first time a truly effective Salmonella control that can be applied prior to the organism being introduced into the processing facility,” stated Justin Reber, President and CEO of OmniLytics, the world’s largest producer of bacteriophage. “We’re confident that reducing the level of Salmonella going into the plant will reduce the contamination of final product being shipped to the consumer.”

Bacteriophage target individual strains and species of bacteria. Unlike indiscriminant broad spectrum antibiotics, the specificity of bacteriophage allows targeting of harmful bacteria without compromising the viability of other beneficial micro flora or fauna. Identified in 1917, bacteriophage or “bacteria eaters” are bacterial viruses that are environmentally friendly, biodegradable, and one of many families of viruses that have no effect on non-target organisms, plants, animals or humans. Bacteriophage are ubiquitous and exist in numbers rivaling even the most prevalent organisms on earth.

OmniLytics has been working with US regulatory agencies since 1994 and in addition to this most recent allowance by the USDA, OmniLytics received the first US registration for a bacteriophage product for its AgriPhage™ product line in December of 2005 and allowance from the USDA/FSIS for bacteriophage treatment of E.coli O157:H7 on livestock hides in December of 2006.

“Salmonella has followed the same path as other bacteria which have been treated for long periods of time with traditional antibiotics and chemicals, and now several Multidrug- Resistant (MDR) “super bug” serotypes of Salmonella have been identified. We believe BacWash can succeed as a long-term solution for controlling MDR Salmonella where these old methods have failed,” added Reber. “Another benefit of bacteriophage specificity is the opportunity to treat many types of contaminant-susceptible foods, on a continuous basis as a preventive measure, since there are no side effects.”

The USDA allowance and immediate availability of these products means that livestock processors may now begin to treat both Salmonella and E. coli O157:H7 using the OmniLytics products.

About OmniLytics, Inc.

OmniLytics is a biotech company focused on developing safe, natural, effective solutions for infectious disease and pest control. OmniLytics is located in SLC, Utah. OmniLytics is pioneering research and development of bacteriophage solutions for control of microorganisms in agricultural, food & water, industrial, pharmaceutical, and defense markets. OmniLytics’ proprietary formulas and processes optimize the use of natural bacteriophage for commercial applications. For more information about OmniLytics, visit www.omnilytics.com.

Contacts:

Press or Product

Tony Swensen
OmniLytics, Inc.
801.746.3600 x304
tswensen@omnilytics.com

Business or Investments

Alan Walbeck
OmniLytics, Inc.
801.746.3600 x320
awalbeck@omnilytics.com

Contact the OmniLytics PR Department Here.